Skip to main content

Table 1 Baseline characteristics of Dutch and all included patients

From: Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

 

Netherlands (N = 1189)

World (N = 52,014)

Female sex, n (%)

504 (42.4)

22,987 (44.2)

Age, mean (sd)

70.7 (9.9)

69.7 (11.5)

 < 65, n (%)

311 (26.2)

15,693 (30.2)

 65–74, n (%)

426 (35.8)

16,948 (32.6)

 ≥ 75, n (%)

452 (38.0)

19,373 (37.2)

BMI (kg/m2), mean (sd)

28.5 (5.3)

27.8 (5.7)

Congestive Heart Failure, n (%)

82 (6.9)

10,397 (20.0)

Hypertension, n (%)

775 (65.5)

39,585 (76.3)

Diabetes Mellitus, n (%)

238 (20.0)

11,540 (22.2)

Stroke/TIA, n (%)

137 (11.5)

5954 (11.4)

PE or DVT, n (%)

22 (1.9)

1356 (2.6)

Coronary artery disease, n (%)

222 (18.7)

11,232 (21.6)

Acute Coronary Syndrome, n (%)

166 (14.0)

4895 (9.5)

Chronic Kidney Disease, n (%)

 None

377 (31.7)

23,919 (46.0)

 Stages 1 to 2

629 (52.9)

16,508 (31.7)

 Stages 3 to 5

118 (9.9)

5373 (10.3)

History of Bleeding, n (%)

25 (2.1)

1317 (2.5)

Hypercholesterolemia, n (%)

422 (36.0)

20,940 (41.6)

CHA2DS2-VASc

3.1 (1.5)

3.2 (1.6)

HAS-BLED

1.4 (0.9)

1.4 (0.9)

Care Setting Speciality at Diagnosis, n (%)

 Cardiology

1097 (92.3)

34,165 (65.7)

 Other Hospital Departments

30 (2.5)

10,434 (20.1)

 Primary Care / General Practice

62 (5.2)

7410 (14.2)

  1. BMI Body mass index, VKA Vitamin K antagonist, NOAC Non-vitamin K antagonist oral anticoagulant, TIA Transient ischaemic attack, PE Pulmonary embolism, DVT Deep venous thrombosis